Category: On-Demand Webinar

Join this webinar to explore key findings from the Global Food Safety Training Survey, such as organizations with a strong training program are 12X more likely to have strong, consistent adherence to established protocols on the floor.     As the most comprehensive research conducted on food manufacturer training, the data provides an opportunity to benchmark your employee training program with industry peers to identify your strengths

Join our expert-led webinar for a comprehensive overview of European regulatory requirements for Active Substance Master Files (ASMFs) and Certificates of Suitability (CEPs). This session will guide pharmaceutical and regulatory professionals through the key frameworks, submission pathways, and ongoing maintenance obligations within the European landscape. We will explore the roles of major regulatory authorities including

FDA is increasing FSVP enforcement—and many importers aren’t prepared for what happens next.  With data-driven targeting and AI-assisted inspections, FDA is identifying high-risk companies faster than ever. The result? More 483 observations, warning letters, import alerts—and compliance failures that become public record.  The problem isn’t just awareness. It’s execution.  In this webinar, we’ll break down what FDA is actually finding during FSVP inspections—and why so many programs fail when

Bringing cosmetic products to market across the EU, UK, and U.S. has never been more complex—or more critical to get right the first time. Increasing regulatory scrutiny, evolving frameworks, and the need for faster innovation are putting pressure on brands to get compliance right from the very beginning, not as an afterthought.  In this focused webinar,

Discover what it takes to confidently market OTC drug products in today’s evolving regulatory landscape.    In this in-depth webinar, we’ll break down the fundamentals of FDA OTC drug compliance—starting with how to determine whether your product qualifies as a cosmetic, a drug, or both. From there, we’ll guide you through the essential components of a

SQF Edition 10 has officially been released, introducing a new digital-first code format along with updated expectations around food safety culture, change management, and risk‑based environmental monitoring. These updates represent one of the most meaningful shifts in the SQF program in recent years, and facilities will need clarity and direction to prepare for future audits.   In this

U.S. FDA oversight continues to evolve toward a more data-driven, risk-based model — and 2026 will reflect deeper scrutiny in areas that directly affect both U.S. importers and foreign food manufacturers.  Inspection data shows sustained focus on FSVP compliance, with food safety plan and hazard analysis deficiencies among the most frequently cited findings. GMP fundamentals — including sanitation, personnel practices,

Understanding FDA Master Files (MFs) is critical for companies preparing regulatory submissions that depend on confidential or proprietary information. This webinar delivers a clear, practical overview of how FDA Master Files operate, who relies on them, and how they support regulatory applications across the drug, biologic, medical device, food, and tobacco industries. Attendees will gain

Many LACF and acidified food manufacturers believe they are in the clear once they have registered their facility and submitted a process filing for an SID number.  However, we are seeing more clients have process filings rejected by the FDA because of significant gaps in supporting documentation—gaps that often lead to returned filings, follow-up questions, or citations. Plus, the FDA

Since 2020, FDA has imposed more requirements on the drug industry. Besides establishment registrations and product listing that have been required for decades, fees are now collected by the FDA on more manufacturers on an annual basis. Amounts of listed drug products are now required to be reported on an annual basis. Stay out of trouble with the FDA ensuring you know

The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) continue to evolve its regulatory framework to enhance drug safety, promote innovation, and improve patient access to effective therapies.   This webinar provides a comprehensive update on the most recent developments at CDER, including changes in review programs, guidance updates, inspection and compliance trends, and

Expanding into North America brings enormous opportunity—but navigating three distinct food-labeling systems can be challenging. This webinar provides a clear, practical roadmap to help manufacturers, brand owners, and exporters understand and meet labeling requirements in the United States, Mexico, and Canada. Join our regulatory experts as they break down the key similarities and differences across

Join this free webinar, where you will learn how to: Recognize what’s new in PCQI 2.0, and why it matters. Utilize new tools such as FDA’s Appendix 1 hazard list. Leverage the updated guidance to enhance your monitoring, corrective action, verification, and recordkeeping practices. Ensure your preventive controls program and PCQI training reflect the latest

Understanding and implementing Unique Device Identification (UDI) requirements can be one of the most complex challenges for medical device professionals. In this session, our labeling and regulatory experts will break down the logic behind medical device labeling and guide you through the most common pitfalls that can delay compliance or create costly errors.  Join us

Join us for an in-depth webinar that unpacks the essential requirements of Cosmetic Regulation (EC) No. 1223/2009, the cornerstone of cosmetic product safety and compliance in the European Union. Designed for manufacturers, brand owners, and regulatory professionals, this session provides a clear, step-by-step explanation of the regulation’s key provisions and how to achieve and maintain

Failure to adequately address observations from an FDA inspection can lead to serious consequences, including warning letters; regulatory meetings; import alerts; seizures of products and operational shutdowns. Responding appropriately to the FDA can mean the difference between continuing operations without interruption and increased regulatory oversight. The purpose of this presentation is to address what you

Fragrance and flavor ingredients are central to cosmetics and personal care products, but they’re also highly regulated due to their complexity and potential allergens. With the 51st Amendment to the International Fragrance Association (IFRA) Standards going into effect on October 30, 2025, the time to act is now.  This significant update introduces new ingredient restrictions,

Did you know that two of the most common reasons food products are refused entry into the U.S. are labeling mistakes and illegal food additives? Many companies don’t discover that their products are not permitted in the U.S. market until it is too late, and they are detained at port. Recent FDA actions add to the

Health Canada Master Files (MFs) are a powerful tool for protecting proprietary information while streamlining regulatory submissions — but navigating their requirements can be complex. Understanding how to prepare, submit, and maintain a compliant Master File is essential to safeguard intellectual property, avoid costly delays, and accelerate product approvals in Canada’s competitive pharmaceutical product market.

Nothing derails supply chains like FDA import detentions. This webinar will help you understand what triggers detentions, how Import Alerts work, and what steps you can take to keep your medical devices moving across borders without delays. Learn best practices for documentation, product coding, and how to respond if issues arise—all backed by real-world scenarios.

The Ministry of Economic Affairs is pleased to announce a webinar presented by Registrar Corp: An Update on US FDA Regulations, Best Practices, and Common Challenges – and Recommended Solutions for the Foreign Exporter. As the U.S. Food and Drug Administration (FDA) continues to update and refine regulations for food and cosmetic products, it’s more

FDA Investigators (Consumer Safety Officers) inspect manufacturers for many reasons, but their process follows consistent guidelines. This webinar will focus on what to expect from an investigator during an inspection, what they may be thinking, and how you can prepare to ensure the inspection goes smoothly.  Topics include:  Who FDA investigators are and how they

Perfect for newcomers and professionals seeking a refresher, this webinar provides a clear, practical introduction to the regulatory framework that governs medical devices in the United States. Learn how the FDA classifies devices, what pathways exist for market entry, and the compliance obligations every manufacturer must understand. 

FDA inspections are inevitable for drug manufacturers — whether to secure pre-approval for a new product, ensure GMP compliance, follow up on post-market reports, or investigate complaints and recalls. While the reason may differ, FDA investigators follow established procedures, and knowing what to expect can make the difference between a smooth inspection and a disruptive